Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta. 1999

L A Paige, and D J Christensen, and H Grøn, and J D Norris, and E B Gottlin, and K M Padilla, and C Y Chang, and L M Ballas, and P T Hamilton, and D P McDonnell, and D M Fowlkes
Novalon Pharmaceutical Corporation, 4222 Emperor Boulevard, Suite 560, Durham, NC 27703, USA.

Estrogen receptor (ER) modulators produce distinct tissue-specific biological effects, but within the confines of the established models of ER action it is difficult to understand why. Previous studies have suggested that there might be a relationship between ER structure and activity. Different ER modulators may induce conformational changes in the receptor that result in a specific biological activity. To investigate the possibility of modulator-specific conformational changes, we have applied affinity selection of peptides to identify binding surfaces that are exposed on the apo-ERs alpha and beta and on each receptor complexed with estradiol or 4-OH tamoxifen. These peptides are sensitive probes of receptor conformation. We show here that ER ligands, known to produce distinct biological effects, induce distinct conformational changes in the receptors, providing a strong correlation between ER conformation and biological activity. Furthermore, the ability of some of the peptides to discriminate between different ER alpha and ER beta ligand complexes suggests that the biological effects of ER agonists and antagonists acting through these receptors are likely to be different.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D004964 Estriol A hydroxylated metabolite of ESTRADIOL or ESTRONE that has a hydroxyl group at C3, 16-alpha, and 17-beta position. Estriol is a major urinary estrogen. During PREGNANCY, a large amount of estriol is produced by the PLACENTA. Isomers with inversion of the hydroxyl group or groups are called epiestriol. (16alpha,17beta)-Estra-1,3,5(10)-Triene-3,16,17-Triol,(16beta,17beta)-Estra-1,3,5(10)-Triene-3,16,17-Triol,16-alpha-Hydroxy-Estradiol,16alpha,17beta-Estriol,16beta-Hydroxy-Estradiol,Epiestriol,Estra-1,3,5(10)-Triene-3,16beta,17beta-Triol,Ovestin,16 alpha Hydroxy Estradiol,16alpha,17beta Estriol,16beta Hydroxy Estradiol
D004965 Estrogen Antagonists Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. Estradiol Antagonists,Antagonists, Estradiol,Antagonists, Estrogen
D004967 Estrogens Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. Estrogen,Estrogen Effect,Estrogen Effects,Estrogen Receptor Agonists,Estrogenic Agents,Estrogenic Compounds,Estrogenic Effect,Estrogenic Effects,Agents, Estrogenic,Agonists, Estrogen Receptor,Compounds, Estrogenic,Effects, Estrogen,Effects, Estrogenic,Receptor Agonists, Estrogen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining

Related Publications

L A Paige, and D J Christensen, and H Grøn, and J D Norris, and E B Gottlin, and K M Padilla, and C Y Chang, and L M Ballas, and P T Hamilton, and D P McDonnell, and D M Fowlkes
January 2005, Anticancer research,
L A Paige, and D J Christensen, and H Grøn, and J D Norris, and E B Gottlin, and K M Padilla, and C Y Chang, and L M Ballas, and P T Hamilton, and D P McDonnell, and D M Fowlkes
November 1998, Endocrinology,
L A Paige, and D J Christensen, and H Grøn, and J D Norris, and E B Gottlin, and K M Padilla, and C Y Chang, and L M Ballas, and P T Hamilton, and D P McDonnell, and D M Fowlkes
December 2013, Bioorganic & medicinal chemistry letters,
L A Paige, and D J Christensen, and H Grøn, and J D Norris, and E B Gottlin, and K M Padilla, and C Y Chang, and L M Ballas, and P T Hamilton, and D P McDonnell, and D M Fowlkes
November 2001, European urology,
L A Paige, and D J Christensen, and H Grøn, and J D Norris, and E B Gottlin, and K M Padilla, and C Y Chang, and L M Ballas, and P T Hamilton, and D P McDonnell, and D M Fowlkes
October 2001, Journal of anatomy,
L A Paige, and D J Christensen, and H Grøn, and J D Norris, and E B Gottlin, and K M Padilla, and C Y Chang, and L M Ballas, and P T Hamilton, and D P McDonnell, and D M Fowlkes
January 2000, Breast cancer research : BCR,
L A Paige, and D J Christensen, and H Grøn, and J D Norris, and E B Gottlin, and K M Padilla, and C Y Chang, and L M Ballas, and P T Hamilton, and D P McDonnell, and D M Fowlkes
January 2004, Breast cancer (Tokyo, Japan),
L A Paige, and D J Christensen, and H Grøn, and J D Norris, and E B Gottlin, and K M Padilla, and C Y Chang, and L M Ballas, and P T Hamilton, and D P McDonnell, and D M Fowlkes
October 2000, Endocrinology,
L A Paige, and D J Christensen, and H Grøn, and J D Norris, and E B Gottlin, and K M Padilla, and C Y Chang, and L M Ballas, and P T Hamilton, and D P McDonnell, and D M Fowlkes
March 2008, The Journal of biological chemistry,
L A Paige, and D J Christensen, and H Grøn, and J D Norris, and E B Gottlin, and K M Padilla, and C Y Chang, and L M Ballas, and P T Hamilton, and D P McDonnell, and D M Fowlkes
October 1998, Steroids,
Copied contents to your clipboard!